Hildred Capital

Hildred Capital Partners, LLC is a family investment firm located in New York City, established in 2014. The firm focuses on investing in a diverse array of securities, including both equity and debt, across various geographies and sectors, utilizing both active and passive management strategies. Hildred Capital Partners has a strong emphasis on private equity, particularly in situations where its principals can leverage their extensive management experience to enhance a company's performance. The firm’s management team possesses significant expertise in multiple fields, including healthcare, finance, real estate, and entertainment, which informs its investment decisions and strategies.

Andrew Goldman

Co-Founder and Managing Partner

9 past transactions

Binx

Series F in 2024
Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Hello Bello

Acquisition in 2023
Hello Bello is an online retailer based in Pacific Palisades, California, specializing in children's goods. Founded in 2018, the company offers a range of products made with plant-based ingredients and organic botanicals. Its product line includes premium diapers, shampoo, body wash, baby wipes, bubble baths, diaper rash cream, sanitizer, and lotion. Hello Bello aims to provide parents with high-quality, affordable options for their children's needs, allowing them to choose from a variety of products that align with their values and budget.

AleraCare

Private Equity Round in 2023
AleraCare Holdings specializes in home and community-based healthcare and pharmacy services, catering to high-need and medically complex populations. The company focuses on the specialty pharmacy and home infusion sectors, providing essential medications and treatments for conditions such as oncology, rheumatoid arthritis, multiple sclerosis, and Crohn's disease. By offering these specialized services, AleraCare supports patients with chronic illnesses, ensuring they receive complex and efficient treatment in a convenient manner.

HealthCare.com

Series C in 2022
HealthCare.com is an online health insurance company that offers a data-driven shopping platform to assist American consumers in enrolling in individual health insurance and Medicare plans. Founded in 2014 and headquartered in New York City, the company utilizes artificial intelligence and machine learning to enhance user experiences, enabling customers to find, compare, and purchase insurance products that best meet their needs. HealthCare.com also markets proprietary health insurance and supplemental insurance products under the name Pivot Health. Its services include a comparison platform that provides expert advice, data, and personalized recommendations, empowering users to make informed decisions regarding their healthcare coverage. The company has been recognized as one of America's fastest-growing businesses, earning a spot on the Inc. 5000 list multiple times.

Binx

Series E in 2021
Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

DermCare Management

Private Equity Round in 2019
DermCare Management is a dermatology practice management company founded by experienced dermatology professionals. It focuses on partnering with dermatologists to enhance patient loyalty and practice growth by combining clinical expertise with management support. The company provides administrative assistance and resources, allowing dermatologists to concentrate on delivering high-quality care. DermCare Management aims to foster a team-oriented environment in healthcare, emphasizing collaboration and effective management to ensure the continued success of its partner practices. Through its services, DermCare Management addresses the unique challenges faced by dermatology practices, enabling them to thrive in a competitive landscape while maintaining a commitment to exceptional patient care.

Crown Laboratories

Private Equity Round in 2019
Crown Laboratories, Inc. is a specialty pharmaceutical company based in Johnson City, Tennessee, founded in 2000. The company focuses on producing both prescription and non-prescription drugs, as well as cosmetic products aimed at enhancing skin health. Its product portfolio includes a range of aesthetic solutions such as SkinPen and Skinfuse, beauty products like Body Blur and Beauty Blur, and therapeutic options including Blue Lizard and PanOxyl. Additionally, Crown Laboratories offers contract manufacturing services for various formulations including solid, liquid, and semi-liquid gels and creams. The company's commitment to dermatology drives its mission to improve the quality of life for consumers through effective skincare solutions.

Crown Laboratories

Private Equity Round in 2017
Crown Laboratories, Inc. is a specialty pharmaceutical company based in Johnson City, Tennessee, founded in 2000. The company focuses on producing both prescription and non-prescription drugs, as well as cosmetic products aimed at enhancing skin health. Its product portfolio includes a range of aesthetic solutions such as SkinPen and Skinfuse, beauty products like Body Blur and Beauty Blur, and therapeutic options including Blue Lizard and PanOxyl. Additionally, Crown Laboratories offers contract manufacturing services for various formulations including solid, liquid, and semi-liquid gels and creams. The company's commitment to dermatology drives its mission to improve the quality of life for consumers through effective skincare solutions.

Pharmaceutics International

Venture Round in 2016
Pharmaceutics International, Inc. is a contract development and manufacturing organization specializing in dosage form development and cGMP manufacturing services for the biotech and specialty pharmaceutical sectors, both in the United States and internationally. Established in 1994 and headquartered in Hunt Valley, Maryland, the company produces a diverse array of dosage forms, including conventional and controlled-release tablets, soft gels, inhalation products, sterile injectables, and various liquid formulations. Additionally, Pharmaceutics International offers comprehensive services such as pre-formulation, clinical trial materials manufacturing, commercial manufacturing, and clinical packaging and labeling. With a focus on enhancing drug quality and patient outcomes, the company employs advanced technologies for bioavailability enhancement and provides regulatory and project management support to its clients, thereby minimizing risks in drug development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.